Highlights from ISMP’s Winter Action Agendas: Opportunities for Shared Learning - On Demand
ISMP faculty reviews priority findings and recommendations from the recent ISMP Medication Safety Alert! Acute Care edition newsletter Action Agendas. ISMP faculty will describe the cause of often-preventable medication safety issues including but not limited to Covid-19 vaccine mix ups, errors with hypertonic saline, monoclonal antibodies errors, and glycemic events. Faculty will discuss meaningful recommendations for early detection as proven prevention strategies.
Participants in this program will learn how they can use this timely information to immediately address issues in their organization in support a robust medication safety program.
Target Audience
Nurses
Physicians
Pharmacist
Pharmacy Tech
Learning Objectives
Nursing, Physician and Pharmacists Learning Objectives:
1. Recall three errors/hazard examples that have been reported to the ISMP Medication Errors Reporting Program (ISMP MERP) during recent months
2. State three strategies to prevent mix ups between adult and pediatric formulations of the Covid-19 vaccine.
3. List two error types associated with the use of hypertonic sodium chloride
4. Describe how external medication safety information can be used proactively to support improved outcomes as part of a robust medication safety program.
Pharmacy Tech Learning Objectives:
1. Recall three errors/hazard examples that have been reported to the ISMP Medication Errors Reporting Program (ISMP MERP) during recent months
2. Describe how external medication safety information can be used proactively to support improved outcomes as part of a robust medication safety program.
Additional Information
Attachment | Size |
---|---|
Helpful Tips for Users - Vizient CE System.docx | 79.2 KB |
Planning committee members
Jackie Stokes, BS
Manager, Pharmacy Program
Vizient
Gretchen Brummel, PharmD, BCPS
Consulting Solutions Director
Vizient
Ellen Flynn, RN, MBA, JD
AVP, Programs
Vizient
Joseph Geskey, DO, MBA, MS-PopH
Principal, Data Science & Member Insights
Vizient
Susan Paparella, MSN, RN
Vice President
ISMP
Presenters
Michael R. Cohen, RPh, MS, ScD (hon.), DPS (hon.), FASHP
President Emeritus ISMP
ISMP
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Institute for Safe Medication Practices (ISMP). Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statement:
NURSING
This activity is designated for 1.00 contact hours.
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-23-004-L05-P
Universal Activity Number: JA0006103-9999-23-004-L05-T
PHYSICIAN
Vizient, Inc. designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 General CE - Attendance